drugset / Trial / NCT00123955

PIE II: Pharmacological Intervention in the Elderly II

NCT00123955

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine whether spironolactone will improve exercise tolerance and quality of life in elderly patients with heart failure preserved ejection fraction (HFPEF).

Timeline

Start
2005-04
Primary completion
2009-06
Completion
2012-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Spironolactone Small molecule 25 mg